Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors.
One hope to maintain the benefits of antiviral therapy against the human immunodeficiency virus type 1 (HIV-1), despite the development of resistance, is the possibility that resistant variants will show decreased viral fitness. To study this possibility, HIV-1 variants showing high-level resistance...
Guardat en:
| Publicat a: | J Virol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1997
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191160/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8995629/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.71.2.1089-1096.1997 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|